Identifying Structural Features Related to the Biological Activity of a Series of AT1 Antagonists from Fragment-based Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-5305|21|6|542-549

ISSN： 0929-8665

Source： Protein and Peptide Letters, Vol.21, Iss.6, 2014-06, pp. : 542-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein crystallography and fragment-based drug design

By Caliandro Rocco   Belviso Danilo Benny   Aresta Brunella Maria   de Candia Modesto   Altomare Cosimo Damiano  

Future Medicinal Chemistry, Vol. 5, Iss. 10, 2013-06 ,pp. : 1121-1140

Future Science

Access to resources Recommend Favorite

Fragment-based drug discovery using NMR spectroscopy

By Harner Mary  

Journal of Biomolecular NMR, Vol. 56, Iss. 2, 2013-06 ,pp. : 65-75

Springer Publishing Company

Access to resources Recommend Favorite

Editorial: Identifying Drug–target Interactions Based on Heterogeneous Biological Data - PART 1

By  

Current Protein and Peptide Science, Vol. 19, Iss. 5, 2018-03 ,pp. : 428-429

Bentham Science Publishers

Access to resources Recommend Favorite

Structural features in heparin that interact with VEGF 165 and modulate its biological activity

By Hattori H.  

Glycobiology, Vol. 9, Iss. 7, 1999-07 ,pp. : 705-711

Oxford University Press

Access to resources Recommend Favorite

Editorial: Identifying Drug-target Interactions Based on Heterogeneous Biological Data - PART 2

By  

Current Protein and Peptide Science, Vol. 19, Iss. 6, 2018-04 ,pp. : 524-524

Bentham Science Publishers

Access to resources Recommend Favorite